Assignee
SUVEN LIFE SCIENCES LTD
IN·42 granted patents·11 pending applications·65 citations·filing 2003–2025
Top patents by PatentIndex Score
53 records- 0189US9957257B2Amide compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 1, 2018·12 cites·9 claims
- 0281US9540321B2Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrateSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jan 10, 2017·5 cites·12 claims
- 0379US7915425B2Process for the preparation of losartanSUVEN LIFE SCIENCES LTD·Filed 2005·Granted Mar 29, 2011·5 cites·11 claims
- 0477US2024277690A1New uses of a 5-ht4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0577US2024293389A1Method of treating cognitive deficits associated with schizophreniaSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0676US8003670B2Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligandsSUVEN LIFE SCIENCES LTD·Filed 2008·Granted Aug 23, 2011·4 cites·8 claims
- 0776US7875605B2N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing themSUVEN LIFE SCIENCES LTD·Filed 2003·Granted Jan 25, 2011·12 cites·9 claims
- 0875US10294217B2Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 21, 2019·1 cites·8 claims
- 0975US7998981B2Aminoaryl sulphonamide derivatives as functional 5-HT6 ligandsSUVEN LIFE SCIENCES LTD·Filed 2005·Granted Aug 16, 2011·4 cites·8 claims
- 1074US7964627B2Amino arylsulfonamide compounds and their use as 5-HT6 ligandsSUVEN LIFE SCIENCES LTD·Filed 2008·Granted Jun 21, 2011·2 cites·8 claims
- 1173US11040026B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Jun 22, 2021·1 cites·16 claims
- 1273US10005711B2Process for large scale production of 1-isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-YL]-[1,3,4]oxadiazol-2-YL}-1H-indazole oxalateSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jun 26, 2018·2 cites·14 claims
- 1371US12285421B2Uses of a 5-HT4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Apr 29, 2025·0 cites·4 claims
- 1469US7297711B2Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing themSUVEN LIFE SCIENCES LTD·Filed 2003·Granted Nov 20, 2007·6 cites·12 claims
- 1568US10308620B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Jun 4, 2019·1 cites·16 claims
- 1668US9328092B2Acrylamide compounds as histamine H3 receptor ligandsSUVEN LIFE SCIENCES LTD·Filed 2012·Granted May 3, 2016·1 cites·6 claims
- 1768US7507835B2N-arylsulfonyl-3-aminoalkoxyindolesSUVEN LIFE SCIENCES LTD·Filed 2003·Granted Mar 24, 2009·4 cites·4 claims
- 1867US9802896B2Process for large scale production of N-[4-(1-cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochlorideSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Oct 31, 2017·1 cites·16 claims
- 1966US9636335B2Heteroaryl compounds as 5-HT4 receptor ligandsSUVEN LIFE SCIENCES LTD·Filed 2015·Granted May 2, 2017·1 cites·21 claims
- 2063US12338236B2Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Jun 24, 2025·0 cites·5 claims
- 2162US7317035B2Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing themSUVEN LIFE SCIENCES LTD·Filed 2003·Granted Jan 8, 2008·2 cites·7 claims
- 2261US12391698B2Substituted piperidines and piperazines and methods for the treatment of CNS disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Aug 19, 2025·0 cites·15 claims
- 2360US2025352540A1Uses of a pure 5-ht6 receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
- 2458US12275746B2Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Apr 15, 2025·0 cites·7 claims
- 2554US10010527B2Active metabolite of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate and dimesylate dihydrate salt of active metaboliteSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jul 3, 2018·0 cites·15 claims
- 2653US7872132B2Intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazoleSUVEN LIFE SCIENCES LTD·Filed 2004·Granted Jan 18, 2011·1 cites·13 claims
- 2752US12122779B2Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Oct 22, 2024·0 cites·12 claims
- 2851US2022409614A1Treating behavioral and psychological symptoms in dementia patientsSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 2950US2019099344A1Topical spray formulation of glycopyrrolateSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
- 3049US12397003B2Amorphous pharmaceutical compositions of abiraterone acetateSUVEN LIFE SCIENCES LTD·Filed 2020·Granted Aug 26, 2025·0 cites·20 claims
- 3149US11458135B2Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Oct 4, 2022·0 cites·38 claims
- 3249US2021346374A1Pharmaceutical compositions of 5-ht6 receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3348US11116764B2Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Sep 14, 2021·0 cites·24 claims
- 3447US11253514B2Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 3547US10973831B2Fluoropiperidine compounds as pure 5-HT 6 receptor antagonistsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Apr 13, 2021·0 cites·11 claims
- 3647US2023000859A1Methods for treating behavioral and psychological symptoms in patients with dementiaSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 3746US2021338661A1New uses of a pure 5-ht 6 receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2018·Application pending·0 cites
- 3845US9790211B25-amino-quinoline-8-carboxamide derivatives as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2013·Granted Oct 17, 2017·0 cites·20 claims
- 3944US7923566B2Alternative process for the preparation of losartanSUVEN LIFE SCIENCES LTD·Filed 2005·Granted Apr 12, 2011·0 cites·18 claims
- 4043US11278530B2Polycyclic amides as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Mar 22, 2022·0 cites·19 claims
- 4143US10603323B2Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Mar 31, 2020·0 cites·26 claims
- 4243US9951045B2Indazole compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Apr 24, 2018·0 cites·7 claims
- 4343US7781476B2Tetracyclic 3-substituted indoles having serotonin receptor affinitySUVEN LIFE SCIENCES LTD·Filed 2003·Granted Aug 24, 2010·0 cites·5 claims
- 4442US12156871B2Substituted azacycles as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Dec 3, 2024·0 cites·9 claims
- 4542US11622967B2Method of treatment with histamine-3 receptor inverse agonistSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Apr 11, 2023·0 cites·17 claims
- 4642US11234979B2Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Feb 1, 2022·0 cites·18 claims
- 4741US2019336509A1Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and nmda receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
- 4840US9783506B2Process for the large scale production of 1H-[1,2,3]triazole and its intermediate 1-benzyl-1H-[1,2,3]triazoleSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Oct 10, 2017·0 cites·7 claims
- 4939US2019336497A1Pharmaceutical compositions of 5-ht6 antagonistSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
- 5038US7649097B2Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing themSUVEN LIFE SCIENCES LTD·Filed 2003·Granted Jan 19, 2010·0 cites·7 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUVEN LIFE SCIENCES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →